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Purpose: This study presents eight-year experience with ablation techniques, recurrent
arrhythmias, and long-term outcomes in patients undergoing catheter ablation for atrial
fibrillation (AF).
Methods: Catheter ablation of AF was performed in 866 consecutive patients in a total of
1272 ablation procedures. Ablation strategy and procedure endpoints were left at the
operator’s discretion. Total study population and groups of paroxysmal (n¼508/59%),
persistent (n¼102/12%), and long-standing persistent AF (n¼256/29%) were evaluated.
Results: Pulmonary vein isolation alone or with cavo-tricuspid isthmus ablation was accom-
plished in 36% of the patients. It was significantly more often used in paroxysmal AF than in
persistent or long-standing persistent AF (both po0.001). More extensive ablation prevailed in
persistent AF types. Ablation was repeated in 307 (35%) patients. Patients with long-standing
persistent AF underwent significantly more repeat procedures than patients with paroxysmal
AF (po0.001) or persistent AF (p¼0.001). Recurrent AF dominated before the first repeat ablation
in 68% cases, while recurrent atrial tachycardia (AT) prevailed before the second (73%), and third
(93%) repeat ablation. Patients with long-standing persistent AF presented with recurrent AT in
50% of the cases already before the first repeat ablation. At the end of 49726 month follow-up,
83% of the patients remained in stable sinus rhythm (SR); 70% of the patients without
antiarrhythmic drugs. SR maintenance was insignificantly superior in long-standing persistent
AF group (91%) compared to paroxysmal AF (82%) and persistent AF patients (68%).
Conclusion: Patients with persistent AF types underwent more extensive initial ablation. Patients
with long-standing persistent AF experienced best long-term outcome likely as a consequence
of higher number of repeat ablation procedures.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Catheter ablation can effectively cure atrial fibrillation (AF),
yet, early as well as late arrhythmia recurrences occur andch Society of Cardiology.
iology, Heart Center Ho
(M. Fiala).multiple procedures of different extent may be required to
eventually restore stable sinus rhythm (SR) [1–4]. Although in
theory absolutely effective, AF ablation in routine clinical
practice still remains limited to a selected population ofPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
spital Podlesı´ a.s. Konska´ 453, Trˇinec 739 61, Czech Republic.
.
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[5].
This retrospective study analyzed ablation techniques,
recurrent arrhythmias, and long-term ablation outcomes in
consecutive patients who underwent ablation procedure for
AF within a period of eight years.2. Methods
2.1. Patient population
The study included 866 consecutive patients, who underwent
catheter ablation for symptomatic AF between June 2003 and
June 2011. These patients underwent a total of 1272 ablation
procedures for AF or residual atrial tachycardia (AT). Repeat
procedures were accomplished by the end of September 2011.
First ablation was performed in the main study center, while
for later working restraints in this center some of the repeat
ablations had to be performed in the second study center.
Follow-up was closed on December 31, 2011, so that the
minimum follow-up period amounted to 6 months since the
first ablation, and 3 months since the last ablation, respec-
tively. The study population was distributed into three groups
of patients with paroxysmal (n¼508/59%), persistent (n¼102/
12%), and long-standing persistent AF (n¼256/29%). Baseline
characteristics are summarized in Table 1.
2.2. Ablation procedure and pre-ablation and
post-ablation management
The details about ablation techniques and pre-ablation and post-
ablation management were described previously [6–9]. Briefly,
warfarin was discontinued and replaced by low-molecular-
weight heparin for 5 days prior to ablation. Laboratory tests
and transthoracic/transesophageal echocardiography were per-
formed o48 h prior to the ablation procedure to exclude
thrombus and to obtain other parameters. Antiarrhythmic drugs
(AADs) were often continued throughout the procedure in the
early stages of our ablation practice, while there was tendency to
discontinue AADs before ablation in the later years.
For the ablation procedure, a 10-pole catheter (Daig, St. Jude,
Minnetonka, MN, USA) was positioned in the coronary sinus
(CS), and a 10-pole ring catheter (Lasso, Biosense Webster,
Diamond Bar, CA, USA) and a mapping/ablation catheterTable 1 – Baseline Characteristics in Total and in Groups by A
Total
(n¼866)
Paroxysmal AF
(n¼508)
Persistent AF
(n¼102)
Females 238 (27%) 153 (30%) 27 (26%)
Age (years) 57710
(21–82)
56710 (21–82) 6179 (32–78)
CHADS2
score
1.271.0
(0–5)
1.171.0 (0–5) 1.370.8 (0–4)
LA diameter
(mm)
4476
(25–76)
4275 (25–61) 4´677 (29–76)
LV EF (%) 5777
(20–72)
5975 (35–72) 5678 (25–65)
AF¼atrial fibrillation; LA¼ left atrial; LS long-standing; LV EF¼ left ventr(ThermoCool or NaviStar ThermoCool, Biosense Webster) were
inserted via two 8 F transseptal sheaths (Daig, St. Jude) in the
left atrium (LA) and pulmonary veins (PVs). Heparin was given
to maintain activated clotting time (ACT) between 250–350 s in
the first years, and 300–400 s in the later years. Bipolar
endocardial electrograms were filtered at a band-pass setting
of 30–500 Hz and displayed at 200mm/s speed (Cardiolab
System, Prucka Engineering, Sugar Land, TX, USA). A few early
ablation procedures were performed conventionally without
using 3-dimensional non-fluoroscopic mapping, while a major-
ity of ablation procedures were guided by 3-dimensional
electroanatomic left atrial (LA) and possibly right atrial (RA)
mapping (CARTO system), (Biosense Webster). Radiofrequency
energy was applied with a Stockert generator (Biosense Web-
ster). The power and temperature limits evolved over time to
finally use irrigation of 17–30 ml/min (heparinized 0.9% saline)
and temperature and power limits of 42 1C and 35W (limited to
20ml/min and 20–25W inside the CS) in the last 5 years.
The extent of ablation strategy and procedure endpoints
differed among the patients; however, full PV isolation validated
by the ring catheter was the mandatory procedure endpoint in
all patients. Patients with long-standing persistent AF invariably
received extensive ablation consisting minimally of the manda-
tory wide-area PV isolation and LA roof and mitral isthmus
linear lesions; AF termination and SR restoration by radiofre-
quency applications were always pursued as an ideal procedure
endpoint. Converted AT, macroreentry or localized, was
characterized according to standard criteria and identified by
the means of activation and entrainment mapping [10].
Heparin was stopped at the end of the procedure, and low-
molecular-weight heparin was administered until warfarin
reached full therapeutic effect. Warfarin was stopped following
a minimum of 6 weeks after uncomplicated PV isolation for
paroxysmal AF up to 6 months after complex ablation for
persistent AF in case of stable SR, preserved LA appendage
outflow velocity (generally Z40 cm/s), and no other conditions
favoring permanent anticoagulation. In the later years, there
was a tendency to avoid re-initiation of AADs; however, they
were sometimes resumed to stabilize SR in the early post-
ablation course.
2.3. Follow-up
Patients were seen at the outpatient department after 6
weeks, 3, 6, 9, and 12 months, and then every 6 months inF Type.
LS Persistent AF
(n¼256)
p Parox-
Pers
p Parox-LS
Pers
p Pers- LS
Pers
58 (23%) 0.583 0.097 0.550
5879 (24–79) o0.001 0.056 0.009
1.370.9 0.028 o0.001 0.792
4875 (33–68) o0.001 o0.001 0.003
5479 (20–67) o0.001 o0.001 0.028
icular ejection fraction, Parox¼paroxysmal; Pers¼persistent.
Fig. 1 – Ablation strategy employed in different AF groups at
the initial ablation. Simple PV isolation dominated in
paroxysmal AF, more extensive ablation including left
atrium outside pulmonary veins, coronary sinus, and right
atrium prevailed in persistent AF types. See details in the
text. PVI¼pulmonary vein isolation, CTI¼cavo-tricuspid
isthmus ablation; LA¼ left atrial extra-pulmonary vein abla-
tion; CS¼coronary sinus ablation; RA¼right atrial ablation;
LS¼ long-standing.
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were later periodically contacted over phone. ECG documen-
tation consisted of 12-lead ECG recordings at every visit and
interim visits at local cardiologists and 24-h ECG recordings
several times a year. In multiple patients, a 2–3-week trans-
telephonic ECG monitoring with loop-recorder every six
months was employed, while many others received an
episodic recorder for daily many ECG recordings, both ran-
dom and during symptoms for up to one-year period.
Arrhythmia recurrence included ECG documented AF/AT,
and also any history of palpitations suggestive of AF/AT
lasting 430 s.
2.4. Data presentation
The outcomes are presented in total and separately for the
three standard AF types (paroxysmal, persistent, and long-
standing persistent) according to the current consensus for
AF treatment [11]. Variability in the arrhyhmogenic sub-
strates with wide overlap among the AF types individualized
ablation strategy. Further, ablation strategy varied depending
on the operator’s discretion, individual skill/learning curve,
and/or preset protocols of studies, in which some of the
patients were included. Finally, radiofrequency energy set-
tings and follow-up density varied due to natural evolution of
the method and means of ECG monitoring available. Therefore,
for the purpose of this retrospective analysis, categorization of
the presented data had to be simplified.
Ablation extent was distributed into 5 categories: (1) PV
isolation (PV encircling with isolation only); (2) PV isola-
tionþcavo-tricuspid isthmus (CTI) ablation; (3) LA ablation
(PV isolationþpossible CTI ablationþdifferent extent of addi-
tional LA ablation outside PVs in terms of linear and/or
electrogram-guided ablation; (4) LA ablationþCS ablation (CS
ablation might include limited distal CS ablation to finalize
mitral isthmus conduction block, or full CS isolation that
eliminated a localized AF sources within the CS, or was
performed during AF ongoing after extensive LA ablation);
and (5) LA ablation (þCS ablation)þRA ablation (RA ablation
might include inter-caval line and/or electrogram-guided
ablation).
Recurrent arrhythmias were classified into (1) paroxysmal
AF; (2) persistent AF; (3) paroxysmal AT; and (4) persistent AT.
If the patient presented with recurrent AT, a single AT type
versus Z2 AT types were differentiated by the means of
invasive mapping. AT decelerated by prior radiofrequency
energy application, or macoreentry AT rotating alternately in
both directions was still considered one distinct AT type.
Final ablation outcome was shown as (1) SR maintenance
with/without AADs; (2) SR maintenance without AADs; (3)
Recurrences of paroxysmal AF/AT; and (4) Recurrence of
persistent AF/AT.
2.5. Statistical analysis
Continuous variables were expressed as mean7standard
deviation and compared by the 2-tailed Student’s t-test for
independent samples. Categorical variables were expressed as
percentages and compared by w2-test. Arrhythmia-free survi-
val in the respective groups was compared by Kaplan–Meiersurvival analysis with log-rank test. A p value o0.05 was
considered significant. STATISTICA vers.6.1 (Statsoft, Inc.)
was used for the analysis.3. Results
3.1. Initial ablation extent
PV isolation alone or with CTI ablation was accomplished in
36% of the patients. It was significantly more often performed
in patients with paroxysmal AF than in patients with persis-
tent or long-standing persistent AF (both po0.001). More
extensive LA ablation was employed in another 38% of the
patients; significantly more often in patients with persistent
AF compared to paroxysmal AF (po0.001) or long-standing
persistent AF (p¼0.002), while there was no difference
between the latter two groups (p¼0.464). LA ablationþCS
ablation, or LA (þCS ablation)þRA ablation were performed
in another 16% and 9% patients, respectively. LA ablationþCS
ablation was more frequently performed in both persistent
AF groups than in paroxysmal AF patients (both po0.001);
there was no difference between persistent and long-
standing persistent AF groups (p¼0.168). Finally, LA ablation
(þCS ablation)þRA ablation was significantly more often
carried out in patients with long-standing persistent AF
compared to paroxysmal or persistent AF patients (both
po0.001) (Fig. 1).3.2. Repeat ablation
The 866 patients underwent a total of 1272 ablation proce-
dures (1.5 procedure/patient). A single ablation was performed
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 6 1 – e 3 6 8e364in 559 (65%) patients, while ablation was repeated in 307 (35%)
patients. Two and three repeat ablation procedures were
performed in 71 (8%) and 14 (2%) patients, respectively.
Patients with long-standing persistent AF underwent two
ablation procedures more often than patients with paroxysmal
AF (po0.001) or persistent AF (p¼0.001). Similarly, they more
frequently underwent three ablation procedures (po0.001 for
comparison with paroxysmal AF group, and p¼0.013 for
comparison with persistent AF group). There we no significant
differences between paroxysmal and persistent AF patients in
the counts of two (p¼0.678) or three (p¼0.728) ablation
procedures (Fig. 2).3.3. Ablation procedure characteristics
Procedure, fluoroscopy, and radiofrequency delivery times of
all 1272 ablation procedures were 272781 (60–600), 29716
(5–105), and 92741 (5–242) min, respectively. Respective times
in different AF groups are compared in Table 2. Procedure
time in paroxysmal AF group was significantly shorter than
the time in persistent AF groups. On the contrary, fluoroscopy
time in the long-standing persistent AF group was signifi-
cantly shorter than in the other groups.Fig. 2 – Repeat ablation procedures in different AF groups.
Patients with long-standing (LS) persistent AF underwent
significantly more repeat (first repeat and second repeat)
ablation procedures.
Table 2 – Ablation Procedure Characteristics
Paroxysmal AF
(n¼692)
Persistent AF
(n¼135)
Procedure time
(min)
263782 290782
Fluoroscopy time
(min)
32719 31717
RF delivery time
(min)
89737 94738
AF¼atrial fibrillation; LS¼ long-standing; Par¼paroxysmal; Pers¼Persist3.4. Recurrent arrhythmias
The spectrum of recurrent arrhythmias evolved with the
number of repeat ablation procedures, and also depended on
the AT type/extent of ablation strategy. AF dominated before
the first repeat ablation in 68% of the cases (paroxysmal
AF—41%, persistent/long-standing persistent AF—27%), while
AT prevailed before the second (73%), and third (93%) repeat
ablation (Fig. 3). There was a clear tendency to more frequentLS Persistent AF
(n¼445)
P Par-
Pers
P Par-LS
Pers
P Pers-LS
Pers
282779 o0.001 o0.001 0.264
237x10 0.531 o0.001 o0.001
96747 0.174 0.014 0.761
ent; Pers¼ long-s persistent; RF¼radiofrequency energy.
Fig. 3 – Proportions of different types of recurrent arrhyth-
mia in all patients undergoing repeat ablation procedures.
Atrial fibrillation (AF) prevailed before the first repeat abla-
tion, atrial tachycardia (AT) represented dominant recurrent
arrhythmia before second and third repeat ablation. Par-
ox¼paroxysmal, Pers¼persistent.
Fig. 5 – Kaplan–Meier curves of arrhythmia-free survival in
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standing persistent AF group (50%) or persistent AF group
(35%) when compared with paroxysmal AF group (14%)
(po0.001 for comparison between long-standing and parox-
ysmal AF; p¼0.041 for comparison between persistent and
paroxysmal AF; p¼0.372 for comparison between persistent
and long-standing persistent AF) (Fig. 4).
Persistent AF/AT prevailed after ablation of primary persis-
tent (in 77% of the cases; p¼0.002) or long-standing persistent
AF (in 83% of the cases; po0.001) compared with paroxysmal
AF group, in which persistent AF/AT recurred after the initial
ablation in only 27% of the cases (Fig. 4).
A single AT versus Z2 ATs were present before repeat
ablation in 65 versus 108 cases, respectively. Presence of Z2
ATs dominated over single AT in all three ablation groups (35
versus 12 in paroxysmal AF group, 10 versus 3 in persistent
AF group, and 63 versus 50 in long-standing persistent AF
group).
3.5. Long-term outcome
Ten (1%) patients (mean age 61712, range 34–78 years) died
31719 (5 -6 0) months after the last ablation. These patients
belonged to the groups of paroxysmal (0.8%), persistent
(0.9%), and long-standing persistent AF (2%). The cause of
death was cancer in 4 patients, cerebral hemorrhage while
taking warfarin with international normalized ratio within
the range 2–3 in 2 patients, aortic dissection in 1 patient,
infective endocarditis as a resistant complication of later
pacemaker implantation in 1 patient, heart failure due to
recurrent myocardial infarction in 1 patient, and motorcycle
accident in 1 young patient. In addition, 1(0.1%) patient with
paroxysmal AF died in the year 2005 of fulminant cardiacFig. 4 – Proportions of recurrent arrhythmias before the first
repeat ablation in the groups of different primary AF types.
Recurrent paroxysmal AF dominated after ablation of par-
oxysmal AF, recurrent persistent AT prevailed after ablation
of long-standing persistent AF. More frequent recurrent
persistent AF after ablation of persistent AF as compared
to dominating AT after long-standing persistent AF ablation
may reflect more extensive initial ablation strategy in the
latter group.
the respective AF groups after the initial (A) and the last
ablation procedure (B).tamponade that developed 26 h after the first ablation
procedure.
Kaplan–Meier curves of arrhythmia-free survival after the
initial and final ablation are shown in Fig. 5. There was a
significantly better AF/AT-free survival in paroxysmal than in
persistent or long-standing persistent AF patients after the
initial ablation (Panel A). This disparity was leveled off after
the final ablation between the paroxysmal and long-standing
persistent AF groups, while the outcome remained signifi-
cantly worse in the persistent AF group (Panel B).
At the end of 49726 (6–102) month total follow-up time,
and 41726 (3–102) month follow-up period since the last
ablation, 717 (83%) patients were in stable SR; 605 (70%)
patients did not use class I or III AAD. Paroxysmal or
persistent AF/AT recurrences continued in 101 (12%) and 48
(5%) patients, respectively. SR maintenance was insignif-
icantly superior in long-standing persistent AF patients [233
(91%) patients] compared to paroxysmal AF patients [415
(82%) patients] (p¼0.335). On the contrary, the worst outcome
was observed in the group of persistent AF [69 (68%) patients
in SR] (p¼0.264 for comparison with paroxysmal AF, p¼0.099
for comparison with long-standing persistent AF) (Fig. 6).
Warfarin use in 810 (94%) patients before ablation was
reduced to 269 (31%) patients at the end of the follow-up
Fig. 6 – Sinus rhythm maintenance at the end of the follow-
up. AAD¼class I or III antiarrhythmic drug; SR¼sinus
rhythm.
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group (89% versus 27% patients; po0.001), persistent AF group
(100% versus 48% patients, p¼0.001), and long-standing-
persistent AF group (100% versus 32% patients, po0.001).
3.6. Complications
Twenty-two patients (2.5%) experienced a major complication
or complication potentially imperiling with long-term con-
sequence. Cardiac tamponade requiring intervention
occurred in 5 (0.6%) patients, embolic stroke with complete
recovery in 4 (0.5%) patients, and transient ischemic attack in
5 (0.6%) patients. Further complications included hemothorax
from arterial or venous bleeding requiring surgical interven-
tion in 2 (0.2%) patients, suprarenal gland adenoma hemor-
rhage due to anticoagulation treated surgically in 1 (0.1%)
patient, protracted neuropraxis of the femoral nerve in 1
(0.1%) patient, pulmonary edema in 1 (0.1%) patient, sepsis
due to atypical pneumonia in 1 (0.1%) patient, and PV
stenosis in 2 (0.2%) patients. Groin vessel complications that
were not listed were treated without sequel. We did not
observe any atrio-esophageal fistula or phrenic nerve palsy.4. Discussion
This retrospective study analyzed long-term outcomes in a
large number of consecutive patients undergoing catheter
ablation for AF. The initial AF ablation was performed in one
center, while for later working restraints in this center, some
of the patients requiring timely repeat ablation had to be
offered cure in another center. As these repeat ablation
procedures were performed by one operator working in both
centers, the study results roughly approximate eight-year
single center experience. At the same time, the study results
also reflected technological progress, evolution of ablation
strategies, variability in the procedure endpoints, and learn-
ing curve of already experienced as well as beginning opera-
tors. The major findings are as follows: (1) At the initial
ablation, simple PV isolation with possible CTI ablation wasperformed in 51% of the patients and was dominating
ablation strategy in treatment of paroxysmal AF; (2) Complex
ablation strategies at the initial procedure prevailed in per-
sistent/long-standing persistent AF; (3) Repeat ablation was
most often performed in the group of long-standing persis-
tent AF; (4) Recurrent AT begun to prevail after the first repeat
ablation, however, constituted half of the recurrent arrhyth-
mias already after the initial extensive ablation for long-
standing persistent AF; (5) Best final long-term maintenance
of SR was achieved in the long-standing persistent AF group.
4.1. Ablation extent
The extent of initial ablation strategy largely depended on the
preset procedure endpoints. In general, extensive extra-PV
ablation was more often required in persistent/long-standing
persistent AF patients, in whom AF termination and SR
restoration by mere radiofrequency energy applications were
pursued as the procedural endpoint of initial ablation. On the
other hand, procedure endpoints markedly varied in parox-
ysmal AF patients. In some of these patients, simple PV
isolation was considered a sufficient initial procedure end-
point [8]. In many others, in case of ongoing arrhythmia
following PV isolation, efforts to restore SR by extra-PV LA/CS
ablation were made. In addition, it was left at the operator’s
discretion, whether arrhythmia noninducibility was tested by
incremental atrial pacing and/or pharmacological provoca-
tion with isoproterol and adenosine following PV isolation,
and whether it was further pursued in case of AF/AT re-
induction. Hence, even in some paroxysmal AF patients,
localized AF/AT sources outside the PVs and/or residual
macroreentry ATwere further targeted.
4.2. Recurrent arrhythmias and repeat ablation
A noticeable disparity was observed between the recurrent
arrhythmias after the initial ablation of paroxysmal, persis-
tent, or long-standing persistent AF, respectively. Long-
standing persistent AF patients presented with recurrent AT
in half of the cases already after the initial ablation, clearly as
a consequence of extensive ablation rendering the atria
incapable of further disorganized fibrillatory activity. Although
these ATs were often labeled as an unwanted proarrhythmic
effect [12,13], they frequently represent rather unmasked
residual arrhythmia easier to re-ablate than recurrent AF
[14]. Many of these ATs originated from a localized source
likely existing prior to any ablation as a ‘‘background’’ AF
driver that was unmasked and could be mapped selectively
only after the initial extensive ablation [15]. Repeat ablation
increased the proportion of recurrent ATs also in the parox-
ysmal AF group, so that the AT dominated before the second
or third repeat ablation in all the groups.
Typically, following ablation of persistent/long-standing per-
sistent AF, again persistent AF/AT recurred, while paroxysmal
arrhythmia (mainly AF) dominated after ablation of paroxys-
mal AF. It may have important clinical implications for
identification of recurrent arrhythmias. In appears that a
majority of persistent AF/AT after ablation of persistent AF
types can be revealed by means of standard follow-up with
low risk of missing asymptomatic AF/AT episodes. Correlation
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 6 1 – e 3 6 8 e367of standard follow-up with longer-term ECG monitoring after
ablation of long-standing persistent AF proved (unlike parox-
ysmal AF) very low incidence of clinically unrecognized AF/AT
recurrences (data not shown).
AF substrate and sources are generally more complex in
persistent AF and usually progress with the duration of
persistent AF phase. Consequently, initial ablation strategy
is commonly extensive, and the need for repeat ablation
procedures is larger [16–18]. However, there are several facts
that might overestimate the contrast in the number of repeat
ablation procedures between patients with long-standing
persistent AF and other AF types. First, patients with long-
standing persistent AF were mostly ablated in prospective
studies. To achieve ideal outcomes, they were frequently
offered a repeat ablation even after several isolated AT
episodes that might have been suppressible by AADs. On
the other hand, in many paroxysmal AF patients, reduction
in the AF/AT burden was occasionally tolerated as good
arrhythmia control, and repeat ablation was not urged.
Second, 26 patients with paroxysmal AF (compared to none
with long-standing persistent AF) previously underwent AF
ablation in another center that was not calculated in this
analysis. Including these ablation procedures, the proportion
of paroxysmal AF patients with repeat ablation would
increase from 28% to 33%. Further, in separate studies, we
have observed improved outcomes of a single ablation for
long-standing AF as our experience increased. To achieve
similar outcomes, repeat ablation was required in only 43%
out of the last 80 patients, while it was needed in more than
60% of the preceding 100 patients. Therefore, outcome of
extensive ablation for persistent or long-standing persistent
AF is likely to improve with experience, and the difference of
single ablation outcomes between long-standing persistent
and paroxysmal AF will be gradually reduced. Finally, the
discrepancy between long-standing persistent and persistent
AF patients (only 25% of whom underwent a repeat ablation)
does not corroborate lower need for repeat ablation in the
latter group. In fact, ablation of persistent AF was the least
effective, and appropriate repeat ablation was not indicated
for other reasons (see below).
4.3. Long-term outcome
Best long-term outcome was achieved in patients with long-
standing persistent AF. Although the potential of extensive/
repeat ablation for favorable long-term rhythm control in
persistent AF types is high [19], the outcome of this study is
rather unexpected [3,5,20,21]. It is likely that the extent of
initial ablation and greater number of repeat ablations can
effectively abolish even very complex arrhythmogenic sources.
On the other hand, PV isolation for paroxysmal AF is more
susceptible to missing possible (and not infrequent) extra-PV
sources, and if repeat ablation concentrates only on PVs again
and does not seek alternative sources, ablation failure and
multiple repeat ablations may be at stake. In this respect, only
1% of long-standing persistent AF patients, but 2% of parox-
ysmal AF patients underwent four ablation procedures.
Obvious discrepancy between worse arrhythmia-free sur-
vival and, on the contrary, slightly better final SR mainte-
nance in the group of long-standing persistent AF has apossible explanation. Following ablation of paroxysmal AF,
recurrences of paroxysmal arrhythmia usually emerged from
unaffected or recovered ectopic focus. First AF/AT recurrence
largely heralded subsequent repeated recurrences (albeit
possibly reduced in quantity and duration), while isolated
AF/AT recurrences were very rare. On the other hand, after
long-standing persistent AF ablation, isolated recurrences of
persistent AT that never re-occurred after cardioversion and/
or adjusted AAD medication were not infrequent.
There are; however, also several facts that may put the
outcome of paroxysmal AF ablation into different light. First,
accidental self-terminating AF/AT episodes in the paroxysmal
AF group were tolerated in some patients as a clinical improve-
ment. On the contrary, rare arrhythmia episodes after ablation
of long-standing persistent AF were often indicated to timely
repeat ablation (see also above). Second, by the end of the
follow-up period, repeat ablations had been accomplished in a
majority of eligible patients with long-standing persistent AF,
while repeat ablation was successfully performed in some of the
patients with paroxysmal AF after the follow-up had been
closed. Finally, practically all ablation procedures for long-
standing persistent AF were performed by the most experienced
operator (note significantly shorter fluoroscopy times in this
group), while learning curve of the beginning operators might
have projected onto the outcomes of paroxysmal AF ablation
Contradictory results in the persistent AF group also
deserve several comments. The persistent AF patients repre-
sented a specific group in some aspects. They were signifi-
cantly older, underwent fewest repeat procedures, and
exhibited worst outcome. Interestingly, they also constituted
the smallest group. It can be speculated that indication to
catheter ablation of long-standing persistent AF was affected
by the presumption that only younger patients would benefit.
Many of these patients entered the category of long-standing
persistent AF by exceeding the 12-month limit of persistent
AF phase thanks to prior multiple pharmacological attempts
to restore SR and the time spent on waiting list. On the other
hand, older patients with persistent AF were frequently
referred to catheter ablation at the stage of paroxysmal AF,
but due to advanced arrhythmogenic substrate shortly devel-
oped persistent AF while awaiting ablation. It is also possible
that the proportion of patients with persistent AF was under-
valued because AF already persistent at the time of ablation
was still counted as paroxysmal AF in some patients. Because
these patients, based on the primary reference, were often
approached as patients with paroxysmal AF, the need to
enhance procedure extent and endpoints beyond PV isolation
could be underestimated, or operators less experienced in
extensive ablation were assigned to perform the procedure.
As a result, the outcome of persistent AF ablation was not
optimal. Simultaneously, the finding of advanced arrhythmo-
genic substrate together with older age might discourage
both physicians and patients from repeat ablation.5. Conclusion
Catheter ablation restored stable SR, and reduced the use of
antiarrhythmic drugs and anticoagulation in a majority of
patients. Patients with persistent AF types underwent more
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 6 1 – e 3 6 8e368extensive initial ablation. Patients with long-standing persis-
tent AF experienced best long-term outcome likely as a
consequence of higher number of repeat ablation procedures.
r e f e r e n c e s
[1] N. Sawhney, R. Anousheh, W. Chen, et al., Five-year out-
comes after segmental pulmonary vein isolation for parox-
ysmal atrial fibrillation, The American Journal of Cardiology
104 (2009) 366–372.
[2] A. Arya, G. Hindricks, P. Sommer, et al., Long-term results
and the predictors of outcome of catheter ablation of atrial
fibrillation using steerable sheath catheter navigation after
single procedure in 674 patients, Europace 12 (2010) 173–180.
[3] W.S. Tzou, F.E. Marchlinski, E.S. Zado, et al., Long-term
outcome after successful catheter ablation of atrial fibrilla-
tion, Circulation: Arrhythmia and Electrophysiology 3 (2010)
237–242.
[4] R. Weerasooriya, P. Khairy, J. Litalien, et al., Catheter ablation
for atrial fibrillation: are results maintained at 5 years of
follow-up, Journal of the American College of Cardiology 57
(2011) 160–166.
[5] R. Cappato, H. Calkins, S.A. Chen, et al., Updated worldwide
survey on the methods, efficacy, and safety of catheter
ablation for human atrial fibrillation, Circulation: Arrhyth-
mia and Electrophysiology 3 (2010) 32–38.
[6] M. Fiala, J. Chovancˇı´k, P. Heinc, et al., Treatment of sympto-
matic intermittent atrial fibrillation by catheter ablation in
the left atrium: immediate and long-term results in 150
patients, Vnitrnı´ Le´karˇstvı´ 51 (2005) 971–983.
[7] M. Fiala, J. Chovancˇı´k, R. Nevrˇalova´, et al., Pulmonary vein
isolation using segmental versus electroanatomical circum-
ferential ablation for paroxysmal atrial fibrillation: over 3-
year results of a prospective randomized study, Journal of
Interventional Cardiac Electrophysiology 22 (2008) 13–21.
[8] M. Fiala, J. Chovancˇı´k, R. Nevrˇalova´, et al., Termination of
long-lasting persistent versus short-lasting persistent and
paroxysmal atrial fibrillation by ablation, Pacing and Clinical
Electrophysiology 31 (2008) 985–997.
[9] M. Fiala, J. Chovancˇı´k, D. Wojnarova´, et al., Results of
complex left atrial ablation of long-lasting persistent atrial
fibrillation, Journal of Interventional Cardiac Electrophysiol-
ogy 23 (2008) 189–198.
[10] M. Hocini, I. Nault, M. Wright, et al., Disparate evolution of
right and left atrial rate during ablation of long-lasting
persistent atrial fibrillation, Journal of the American College
of Cardiology 55 (2010) 1007–1016.
[11] H. Calkins, K.H. Kuck, R. Cappato, J. Brugada, A.J. Camm, S.A.
Chen, et al., 2012 HRS/EHRA/ECAS expert consensusstatement on catheter and surgical ablation of atrial fibrilla-
tion: recommendations for patient selection, procedural
techniques, patient management and follow-up, definitions,
endpoints, and research trial design, Heart Rhythm 9 (2012)
632–696.
[12] C. Pappone, F. Manguso, G. Vicedomini, et al., Prevention of
iatrogenic atrial tachycardia after ablation of atrial fibrilla-
tion: a prospective randomized study comparing circumfer-
ential pulmonary vein ablation with a modified approach,
Circulation 110 (2004) 2036–3042.
[13] N. Sawhney, R. Anousheh, W. Shen, et al., Circumferential
pulmonary vein ablation with additional linear ablation
results in an increased incidence of left atrial flutter com-
pared with segmental pulmonary vein isolation as an initial
approach to ablation of paroxysmal atrial fibrillation, Circu-
lation: Arrhythmia and Electrophysiology 3 (2010) 243–248.
[14] T. Rostock, I. Drewitz, D. Steven, et al., Characterization,
mapping, and catheter ablation of recurrent atrial tachycar-
dia after stepwise ablation of long-lasting persistent atrial
fibrillation, Circulation: Arrhythmia and Electrophysiology 3
(2010) 160–169.
[15] S.M. Narayan, D.E. Krummen, W.J. Rappel, Clinical mapping
approach to diagnose rotors and focal impulses for human
atrial fibrillation, Journal of Cardiovascular Electrophysiology
3 (2012) 447–454.
[16] M. Haı¨sssaguerre, M. Hocini, P. Sanders, et al., Catheter
ablation of long-lasting atrial fibrillation: clinical outcome
and mechanisms of subsequent arrhythmias, Journal of
Cardiovascular Electrophysiology 16 (2005) 1138–1147.
[17] T. Rostock, D. Steven, B.A. Hoffmann, et al., Chronic atrial
fibrillation is a biatrial arrhythmia: data from catheter abla-
tion of chronic atrial fibrillation aiming arrhythmia termina-
tion using a sequential ablation approach, Circulation:
Arrhythmia and Electrophysiology 1 (2008) 344–353.
[18] M.D. O’Neill, M. Wright, S. Knecht, et al., Long-term follow-
up of persistent atrial fibrillation ablation using termination
as a procedural endpoint, European Heart Journal 30 (2009)
1105–1112.
[19] T. Rostock, T.V. Salukhe, S.D. Drewitz, et al., Long-term
single- and multiple-procedure outcome and predictors of
success after catheter ablation for persistent atrial fibrilla-
tion, Heart Rhythm 8 (2011) 1391–1397.
[20] A. Sorgente, P. Tung, J. Wylie, et al., Six year follow-up after
catheter ablation of atrial fibrillation: a palliation more than
a true cure, American Journal of Cardiology 109 (2012)
1179–1186.
[21] T.F. Chao, H.M. Tsao, Y.J. Lin, et al., Clinical outcome of
catheter ablation in patients with nonparoxysmal atrial
fibrillation: results of 3-year follow-up, Circulation: Arrhyth-
mia and Electrophysiology 5 (2012) 514–520.
